Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment.

Abstract

BACKGROUND:

There are no prospectively collected data available on the natural history of peanut allergy in early childhood. Previous studies of predictors of tolerance development have been biased by failure to challenge high-risk children when IgE antibody levels are high, therefore potentially introducing bias to persistent allergy.

OBJECTIVES:

We sought to describe the natural history of peanut allergy between 1 and 4 years of age and develop thresholds for skin prick test (SPT) results and specific IgE (sIgE) levels measured at age 1 and 4 years that have 95% positive predictive value (PPV) or negative predictive value for the persistence or resolution of peanut allergy.

METHODS:

One-year-old infants with challenge-confirmed peanut allergy (n = 156) from the population-based, longitudinal HealthNuts Study (n = 5276) were followed up at 4 years of age with repeat oral food challenges, SPTs, and sIgE measurements (n = 103). Challenges were undertaken in all peanut-sensitized children at 1 and 4 years of age, irrespective of risk profile.

RESULTS:

Peanut allergy resolved in 22% (95% CI, 14% to 31%) of children by age 4 years. Decreasing wheal size predicted tolerance, and increasing wheal size was associated with persistence. Thresholds for SPT responses and sIgE levels at age 1 year with a 95% PPV for persistent peanut allergy are an SPT-induced response of 13 mm or greater and an sIgE level of 5.0 kU/L or greater. Thresholds for SPT and sIgE results at age 4 years with a 95% PPV for persistent peanut allergy are an SPT response of 8 mm or greater and an sIgE level of 2.1 kU/L or greater. Ara h 2, tree nut, and house dust mite sensitization; coexisting food allergies; eczema; and asthma were not predictive of persistent peanut allergy.

CONCLUSION:

These thresholds are the first to be generated from a unique data set in which all participants underwent oral food challenges at both diagnosis and follow-up, irrespective of SPT and sIgE results.

• Authors: Rachel L Peters, Katrina J Allen, Shyamali C Dharmage, Jennifer J Koplin, Thanh Dang, Kate P Tilbrook, Adrian Lowe, Mimi L K Tang, Lyle C Gurrin, HealthNuts Study
• Journal: The Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 135 Issue 5 Pg. 1257-66.e1-2 (May 2015) ISSN: 1097-6825 [Electronic] United States
• PMID: 25725989 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Chemical References

• Allergens
• Immunoglobulin E

Topics

• Age Factors
• Allergens (immunology)
• Arachis (adverse effects)
• Australia (epidemiology)
• Child, Preschool
• Comorbidity
• Female
• Follow-Up Studies
• Humans
• Immune Tolerance (immunology)
• Immunoglobulin E (immunology)
• Infant
• Infant, Newborn
• Male
• Peanut Hypersensitivity (epidemiology, immunology)
• Population Surveillance
• Risk Factors